Berkshire Arts & Technology Charter Public School will host its first World Cube Association Competition in nearly 10 years on Jan. 24, with up to 75 competitors racing to solve ...

Engineered bearings and power transmission products manufacturer and distributor Solve Industrial Motion Group has acquired D&D Global — a conveyor bearings manufacturer headquartered in Rock Valley, ...

It’s officially a deal spree for Solve Industrial Motion. The engineered bearings and power transmission products distributor announced Oct. 27 the acquisition of Miller Bearing Company — a conveyor ...

What began as a shared hobby in elementary school grew into a student-run speedcubing competition that brought more than 100 ...

Solve Intelligence, the AI platform for the $200B+ patent industry, has raised $40M in Series B funding and is launching a new product for generating patent claim charts. Solve’s Series B comes just ...

The new round, which follows a $12 million Series A earlier this year, includes participation from Thomson Reuters and the founder of Quinn Emanuel’s IP litigation practice. Solve Intelligence ...

Funding round was led by Yosemite, with participation from new investors Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, and all existing investors SAN ...

SAN DIEGO--(BUSINESS WIRE)--Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...

The startup, which is backed by a dozen investors including Merck & Co., claims its novel “linkers” can help address some of the issues limiting the potential of earlier ADCs. Many of these newer ...

Solve Therapeutics, a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for solid tumor malignancies, has raised $120 million in an oversubscribed and upsized financing ...